BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/29/2021 11:12:00 AM | Browse: 314 | Download: 505
 |
Received |
|
2021-03-19 20:39 |
|
Peer-Review Started |
|
2021-03-19 20:43 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-05-01 03:40 |
|
Revised |
|
2021-05-08 02:03 |
|
Second Decision |
|
2021-08-31 03:34 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-08-31 09:11 |
|
Articles in Press |
|
2021-08-31 09:11 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-09-26 11:20 |
|
Publish the Manuscript Online |
|
2021-09-29 11:12 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Farah Albader, Petra Anna Golovics, Lorant Gonczi, Talat Bessissow, Waqqas Afif and Peter Laszlo Lakatos |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Peter Laszlo Lakatos, MD, PhD, Professor, Staff Physician, Division of Gastroenterology, McGill University, 1650 Cedar Avenue, Montreal H3G 1A4, Quebec, Canada. kislakpet99@gmail.com |
| Key Words |
Therapeutic drug monitoring; Inflammatory bowel disease; Biologic therapies; Loss of response; Reactive; Proactive |
| Core Tip |
In this review, we discuss the existing studies that looked at both proactive and reactive therapeutic drug monitoring (TDM) and concluded that in current practice, reactive TDM has been shown to be useful. When used as an adjunct to clinical assessment and biomarkers in patients with treatment failure, TDM has proven to be a valuable tool for subsequent management. |
| Publish Date |
2021-09-29 11:12 |
| Citation |
Albader F, Golovics PA, Gonczi L, Bessissow T, Afif W, Lakatos PL. Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring. World J Gastroenterol 2021; 27(37): 6231-6247 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i37/6231.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i37.6231 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
